{"filing":{"accession_number":"0001437749-26-027314","cik":"0001831868","ticker":"ICUCW","company_name":"SeaStar Medical Holding Corp","form":"8-K","filing_date":"2026-08-12","report_date":"2026-08-12","primary_document":"icu20260607_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926027314/icu20260607_8k.htm"},"events":[{"id":27202,"run_id":24775,"accession_number":"0001437749-26-027314","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"SeaStar Medical issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $0.6 million (82% increase vs. Q2 2025), net loss of $3.7 million, and cash position of $7.0 million. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The filing includes detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.","company_name":"SeaStar Medical Holding Corp","ticker":"ICUCW","filing_date":"2026-08-12","form":"8-K","submitted_at":null,"items":[{"id":28625,"accession_number":"0001437749-26-027314","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"SeaStar Medical issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $0.6 million (82% increase vs. Q2 2025), net loss of $3.7 million, and cash position of $7.0 million. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The filing includes detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:16:43.319705+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28625,"accession_number":"0001437749-26-027314","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"SeaStar Medical issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $0.6 million (82% increase vs. Q2 2025), net loss of $3.7 million, and cash position of $7.0 million. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The filing includes detailed financial tables and operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:16:43.319705+00:00","company_name":"SeaStar Medical Holding Corp","ticker":"ICUCW","filing_date":"2026-08-12"}]}